← Back
$IKT All transactions

Inhibikase Therapeutics, Inc.

A

$ Value

$0

Shares

1,100,705

Price

$0

Filed

Jul 2

Insider

Name

Cabell Christopher

Title

President & Head of R&D

CIK

0001814928

Roles

Officer

Transaction Details

Transaction Date

2025-02-21

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,100,705

Footnotes

The Reporting Person's Form 4 filed with the SEC on February 25, 2025 inadvertently reported an incorrect exercise price with respect to the stock option award originally granted on February 21, 2025. This amendment is being filed solely to correct the exercise price. | The options will vest in three substantially equal installments on the second, third and fourth anniversaries of February 21, 2025, subject to the Reporting Person's continued services through such date.

Filing Info

Accession No.

0000950170-25-093445

Form Type

4/A

Issuer CIK

0001750149

Cabell Christopher's History

Date Ticker Type Value
2025-02-21 IKT A $0

Other Insiders at IKT (90d)

No other insider activity at this issuer in the last 90 days.